— Know what they know.
Not Investment Advice
Also trades as: GMAB (NASDAQ) · $vol 127M · GMAB.CO (CPH) · $vol 55M · GE9.F (FSX) · $vol 0M

GNMSF OTC

Genmab A/S
1W: +21.9% 1M: +29.1% 3M: +56.5% YTD: +42.5% 1Y: +50.6% 3Y: +51.1% 5Y: +0.1%
$439.05
-8.50 (-1.90%)
After Hours: $441.73 (+2.68, +0.61%)
Weekly Expected Move ±10.1%
$357 $402 $448 $493 $538
OTC · Healthcare · Biotechnology · Tech Score Buy · Power 76 · $26.8B mcap · 56M float · 0.0022% daily turnover · Short 43% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $6.49 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.48B.
Distance to default 7.47 (Merton model): prices to 2026-10-23, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☀️
Sunny
+28.0% YTD avg
Midterm Year
⛈️
Stormy
-15.1% YTD avg
2026 Now
☀️
Sunny
Above typical
20yr Avg YTD
+28.0%
Day 206 of 252
Midterm Year YTD
-15.1%
Presidential cycle avg
2026 YTD
+39.8%
Above 20yr avg
Typical Vol
41%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+2.4%
Midterm
🌧️
-1.1%
47% win 42% vol
Feb
20yr
💨
+4.3%
Midterm
⛅
+2.1%
47% win 48% vol
Mar
20yr
⛈️
+4.6%
Midterm
☁️
+0.3%
65% win 46% vol
Apr
20yr
💨
+7.2%
Midterm
⛈️
-6.5%
53% win 36% vol
May
20yr
💨
+14.4%
Midterm
⛈️
-20.3%
59% win 51% vol
Jun
20yr
⛈️
+10.7%
Midterm
⛈️
-19.8%
53% win 39% vol
Jul
20yr
💨
+18.6%
Midterm
⛈️
-13.1%
76% win 47% vol
Aug
20yr
💨
+19.8%
Midterm
⛈️
-13.1%
65% win 55% vol
Sep
20yr
💨
+26.7%
Midterm
⛈️
-12.1%
35% win 42% vol
Oct
20yr
💨
+27.4%
Midterm
⛈️
-12.8%
53% win 41% vol
Now: +23.7%
Nov
20yr
💨
+27.8%
Midterm
☁️
-0.3%
62% win 40% vol
Dec
20yr
💨
+3.4%
Midterm
💨
+5.3%
50% win 52% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +39.8%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms